PREVENTION OF Β THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

PREVENTION OF Β THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

Background:β Thalassemia major is characterized by hemolytic anemia, ineffectiveerythropoiesis and hemosiderosis. About 4 % of the world population carries a Thalassemiagene. Management includes blood transfusions and iron chelation, this treatmentis costly and population screening may be significan...

Full description

Bibliographic Details
Main Authors: Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim
Format: Article
Language:English
Published: PAGEPress Publications 2014-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Thalassemia, Prevention, Treatment, Cost benefit
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/1382

Internet

http://www.mjhid.org/index.php/mjhid/article/view/1382

Similar Items